Systematic analysis of blood ACE levels in patients with all ACE mutations is likely to have clinical significance because available sequencing data will help detect persons with increased risk of late-onset Alzheimer’s disease. This evidence concerns the gene ACE and early-onset autosomal dominant Alzheimer disease.